Thromb Haemost 1981; 45(01): 073-076
DOI: 10.1055/s-0038-1650132
Original Article
Schattauer GmbH Stuttgart

Recent Investigations of the First Bleeder Family in Åland (Finland) Described by von Willebrand

D Nyman
1)   Department of Blood Coagulation Disorders, Karolinska Hospital, 104 01 Stockholm, Sweden
,
A W Eriksson
2)   Institute of Human Genetics, Free University, 1007 MC Amsterdam, The Netherlands
,
M Blombäck
1)   Department of Blood Coagulation Disorders, Karolinska Hospital, 104 01 Stockholm, Sweden
,
R R Frants
2)   Institute of Human Genetics, Free University, 1007 MC Amsterdam, The Netherlands
,
P Wahlberg
3)   Folkhälsan Institute of Genetics Unit, Helsiniki, Finland and Åland Central Hospital, Marieham, Åland, Finland
› Author Affiliations
Further Information

Publication History

Received 04 August 1980

Accepted 18 December 1980

Publication Date:
04 July 2018 (online)

Summary

The still living members of the original bleeder family on the Åland Islands described by von Willebrand in 1926 have been reinvestigated by using modem laboratory techniques for the measurement of the Factor VIII complex and with regard to platelet aggregation. The low level of F VIII: C activity demonstrated in 1957 could be confirmed in some of the family members, who however all had only mild bleeding symptoms. More consistently, in 6 out of 10, a low F VIIIR: Ag was found; all of those also had a low F VIII: RCoF. In none of the members were excessively low values for any of the parameters found. However, the spectrum of the whole F VIII complex indicates that the original family described by von Willebrand belongs to von Willebrand’s disease, type I.

 
  • References

  • 1 von Willebrand EA. Hereditär pseudohämofili. Finska Läkarsällskapets Handlingar 1926; 68: 87-112
  • 2 von Willebrand EA. Über hereditäre Pseudohamophilie. Acta Med Scand 1931; 76: 521-550
  • 3 von Willebrand EA, Jürgens R. Über ein neues Blutungsübel: Die konstitutionelle Thrombopathie. Dtsch Z Klin Med 1933; 175: 453-583
  • 4 Ivy AC, Shapiro PR, Melnick P. The bleeding tendency in jaundice. Surg Gynecol Obstetr 1935; 60: 781-784
  • 5 Kristensson A. A new method for direct counting of the so-called blood platelets in man. Acta Med Scand 1923; 57: 301-312
  • 6 Born CV R. Aggregation of blood platelets by adenosine disphosphate and its reversal. Nature 1962; 194: 927-929
  • 7 Nyman D, Eriksson AW, Lehmann W, Blombäck M. Inherited defective platelet aggregation with arachidonate as the main expression of a defective metabolism of arachidonic acid. Thrombos Res 1979; 14: 739-746
  • 8 Stibbe J. Effect of exercise on F Vlll-complex: Proportional increase of Ristocetin co-factor (von Willebrand factor) and F VIII-AgN, but disproportional increase of FVIII-AHF. Thrombos Res 1977; 10: 163-168
  • 9 Nilsson IM, Blombäck M, von Francken I. On an inherited autosomal hemorrhagic diathesis with antihemophilic glubulin (AHG) deficiency and prolonged bleeding time. Acta Med Scand 1957; 159: 35-57
  • 10 Zimmermann TS, Ratnoff OD, Powell EA. Immunologic differentiation of classic hemophilia (Factor VIII deficiency) and von Willebrand’s disease. J Clin Invest 1971; 50: 244-254
  • 11 Larrieu MJ, Meyer D, Ardaillou N. Syndrome de Willebrand. A propos de 48 observations. Nouv Rev Fr Hématol 1977; 18: 371-381
  • 12 Holmberg L, Nilsson IM. Genetic variants of von Willebrand’s disease. Brit Med J 1972; 03: 317-320
  • 13 Eriksson AW. Eine neue Blutersippe mit von Willebrand-Jiirgens’sche Krankheit (erbliche Thrombopathie) auf Åland (Finnland). Acta Gen Med (Roma) 1961; 10: 157-180
  • 14 Eriksson AW. Ulcus gastroduodenale und Blutungen aus dem oberen Gastrointestinaltrakt in den Ålandischen Blutersippen (von Willebrand-Jiirgens’sche Krankheit, erbliche Thrombopathie). Med Weft 1962; 07: 350-355
  • 15 Eriksson AW, Forsius H, Lehmann W. Capillary permeability as measured by the Amsler-Huber fluorescein test in bleeder families on the Aland Islands. Thrombos Diathes Haemorrh 1964; 10: 438-454
  • 16 Lehmann W, Jürgens AW, Eriksson AW. The platelet function of the thrombopathy on the Åland Islands. Thrombos Diathes Haemorrh 1964; 12: 148-168
  • 17 Eriksson AW, Fellman JO, Forsius HR. Some genetics and clinical aspects of the Aland Islanders. In: Population Structure and Genetic Disorders. Eds. Eriksson AW. et al. Academic Press; New York and London: 1980: 509-536
  • 18 Lehmann W, Eriksson AW, Forsius HR. Von Willebrand-Jürgens Syndrome on Aland. In: Population Structure and Genetic Disorders. Eds. Eriksson AW. et al. Academic Press; New York and London: 1980: 537-546
  • 19 Nyman D, Blombäck M, Lehmann W, Frants RR, Eriksson AW. Blood coagulation studies in bleeder families on the Aland Islands. In: Population Structure and Genetic Disorders. Eds. Eriksson AW. et al. Academic Press; New York and London: 1980: 547-552
  • 20 Jurgens R, Lehmann W, Wegelius O, Eriksson AW, Hiepler E. Mitteilung über den Mangel an Antihämophilen Globulin (Faktor-VIII) bei der Aaländischen Thrombopathie (v. Willebrand-Jürgens). Thrombos Diathes Haemorrh 1957; 01: 257-260
  • 21 Nilsson IM, Blombäck M, Jorpes E, Blombäck B, Johansson SA. Von Willebrand’s disease and its correction with human plasma fraction I-O. Acta Med Scand 1957; 159: 179-188
  • 22 Lian EC-Y, Deykin D. Diagnosis of von Willebrand’s disease. Am J Med 1976; 06: 344-356
  • 23 Eriksson AW, Hiepler E, Jürgens R, Lehmann W, Schulz H. Untersuchung zur Thrombopathie (v. Willebrand-Jürgens). Klin Wschr 1961; 39: 32-42